Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1tn market valuation, a sharp turnaround from ...

Eli Lilly and Company made history on Friday, November 21, 2025, becoming the first healthcare company to achieve a $1 trillion market capitalization. The pharmaceutical giant briefly crossed this ...

Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, ...

Eli Lilly became the first drugmaker to reach a $1 trillion market valuation on Friday, driven by the rapid growth of its ...

Eli Lilly is poised to become the first $1 trillion pharmaceutical company, driven by explosive growth in its weight-loss ...

Starting April 1, 2026, Medicare will begin covering Lilly’s leading weight loss drug, Zepbound, along with Mounjaro, at $245—a 55% discount from current net prices, according to Leerink Partners.

HSBC analyst Rajesh Kumar removed his reduce recommendation and upgraded S&P 500 component company Eli Lilly (NYSE: LLY) stock to hold with a $700 price target today. “Orforglipron’s ATTAIN-2 Phase 3 ...

U.S. stocks wavered amid increased volatility on Friday but managed to resurge, as Wall Street was rattled by concerns on the health of regional banks and credit risks while the U.S. government ...